Similarly, another research showed that there was negative regulation between JMJD6 and Mir-106a-5p in cisplatin-resistant lung cancer cells, inhibition of JMJD6 reduced the proliferation, invasion and migration capacity, and thus alleviated the resistance of cisplatin (42). Here, JMJD6 is linked to lung carcinoma.